查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532952

光學成像市場：2024-2029 年預測

Optical Imaging Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

光學成像市場預計將從 2024 年的 29.39 億美元增加到 2029 年的 46.67 億美元，複合年成長率為 9.69%。

光學成像使用光捕獲身體組織和細胞的圖像，然後從組織成分和生物分子過程推斷資訊。它使用從紫外線到近紅外光的光子來產生圖像。有多種類型，例如光同調斷層掃瞄（OCT）、內視鏡檢查和光聲成像。

此類影像主要被研究人員、生物技術人員和藥劑師用於小動物模型研究和臨床應用，例如癌症和淋巴瘤檢測、婦科惡性研究、體內影像、DNA研究、新生兒和成人腦部影像。光學成像借助非電離輻射減少患者接觸有害輻射的機會。它廣泛應用於生物醫學研究和醫學。

光學成像市場促進因素：

  • 生物醫學和生物製藥研究的加速成長預計將推動市場擴張

光學成像是一項重要技術，可為研究人員、藥劑師和生物技術人員提供研究複雜的人類、動物和植物模型的有用資訊。生物醫學、生物製藥和醫療保健（尤其是眼科）的研究正在促進光學影像市場的成長。根據美國職業安全與健康研究所（NIOSH）的報告，美國每天約有 2000 名工人遭受與工作相關的眼外傷並需要治療。

  • 慢性病增加加速市場擴張

準確的青光眼篩檢需要使用新的光學成像技術進行早期診斷和治療，以阻止進展為失明。活體成像，特別是全身活體成像，可以研究人類疾病的動物模型，減少動物實驗的比例，為科學研究提供必要的資訊。 Vivo 成像的其他應用包括微生物學中使用的生物發光和臨床研究中常用的 Vivo 成像螢光方法。

  • 新科技發展加速市場拓展

例如，CT（電腦斷層掃描）、MRI（磁振造影）和PET-CT（位置發射斷層掃描-電腦斷層掃描）等新技術發展廣泛應用於醫學影像技術。此外，也推出了新軟體來增強光學成像。例如，2023年10月，雅培實驗室發布了Ultreon 1.0，這是一款整合了人工智慧和光學相干斷層掃描（OCT）的血管成像軟體。

研究人員正在研究 3D 光學成像和 3D 顯示在醫學、機器人、安全、檢測、視覺化和顯示功能等領域的應用。例如，3D醫學影像是一項改善診所和手術室疾病預防、診斷和治療的新技術。光學成像生物發光、化學冷光發光、餘輝成像以及使用具有宏觀介觀區域的NIR-II探針的成像探針是深層組織成像研究的新進展。

限制光學成像市場的因素：

  • 缺乏臨床專業知識限制了市場成長

光學成像為疾病檢測和癌症治療提供了巨大的潛力。然而，最佳成像、吸收和散射問題的普遍性較低，以及臨床設備和專業知識的缺乏可能會阻礙光學成像市場的成長。

光學成像市場的地域展望

  • 預測期內，北美將佔據光學成像市場的主要佔有率

由於研究和技術進步不斷增加，以及主要應用光學成像進行更好診斷的眼、腦、癌症和其他疾病的擴散，預計北美將佔據重要的市場佔有率。此外，Heidelberg Engineering Inc.、Carl Zeiss Meditec、Bruker Corporation 和 Leica Microsystems 等市場參與企業的成熟存在也對該地區的市場成長產生了積極影響。

區域經濟體，即美國，視力障礙的盛行率很高。根據美國疾病管制與預防中心 (CDC) 的數據，美國40 歲以上的人中約有 1,200 萬人患有視力喪失，其中近 800 萬人仍未接受治療。主要眼疾包括青光眼、糖尿病性視網膜病變、白內障和屈光不正。

腦部疾病，主要是阿茲海默症、腦腫瘤、失智症和帕金森氏症，是造成美國許多人死亡的原因。此外，核磁共振掃描是一種用於檢測大腦影像並推斷結果的技術。乳癌和腦腫瘤是美國癌症相關死亡的主要原因之一。

電腦斷層掃描 (PET-CT) 掃描和發射斷層掃描等影像技術用於更準確地確定癌症的階段及其在體內擴散的程度。此外，人工智慧等新技術也被引入醫學成像應用，為光學成像提供了新的成長前景。

此外，除了在醫療應用方面具有巨大潛力外，光學成像也正在進入太空任務，美國太空總署等主要太空機構正在投資此類技術。

光學成像市場的主要發展

  • 2024 年 4 月：Spectral Instruments Imaging 宣布推出最新版本的 Vivo 光學成像軟體「Aura 4.5」。基於精確的自動化和專有的動力學模式演算法捕獲和分析即時動態生物發光訊號。
  • 2024 年 2 月：布魯克公司宣布收購 Spectral Instruments Imaging LLC，這是臨床前體內光學影像系統開發專家。此次收購將使布魯克能夠擴大其用於疾病研究的 BioSpin 臨床前成像部門。
  • 2023 年 10 月：雅培實驗室宣佈在印度推出新型血管影像軟體「Ultreon 1.0」。全球首款結合人工智慧和光學相干斷層掃描 (OCT) 的血管內影像軟體，可為醫生提供冠狀動脈閉塞和血流的全面視圖。
  • 2023 年 9 月：Revvity Inc. 推出 IVIS(R) Spectrum 2、IVIS SpectrumCT 2 和 Quantum GX3 microCT 影像系統，旨在推動臨床前研究方法的創新。這些標準產品旨在提高體內和體外領域的靈敏度水平。 光學成像。
  • 2023 年 9 月：Yole 集團合作夥伴 PISEO 宣布推出光學影像測試服務。這些服務使用可靠、最先進的設備來表徵高付加醫療領域的整個光學成像鏈。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章光學成像市場：依技術分類

  • 介紹
  • 內視鏡檢查
  • 光學同調斷層掃描(OCT)
  • 光聲成像
  • 拉曼光譜
  • 超高解析度顯微鏡（SRM）
  • 漫射光學斷層掃描 (DOT)

第6章光學影像市場：依應用分類

  • 介紹
  • 眼科
  • 瘤
  • 牙科
  • 皮膚科
  • 神經
  • 其他

第7章光學成像市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 以色列
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 印度
    • 印尼
    • 台灣
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • ZEISS Group
  • Leica Microsystems
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • Santec Corporation
  • Luneau Technology USA
  • Headwall Photonics
  • Koninklijke Philips NV
  • NIDEK CO., LTD.
簡介目錄
Product Code: KSI061610434

The optical imaging market is poised to reach US$4.667 billion in 2029 from estimated value of US$2.939 billion in 2024 at 9.69% (CAGR).

Optical imaging uses light to obtain images of body tissue or cells, before which the information is deduced from tissue composition and biomolecular processes. It generates images using photons of light from ultraviolet to near-infrared. Such imaging comprises various types, such as optical coherence tomography (OCT), endoscopy, and photoacoustic imaging, among others.

Optical Imaging is primarily used by researchers, biotechnicians, and pharmacists to study small animal models and clinical applications, such as the detection of cancer and lymphoma, the study of gynaecologic malignancies, in vivo imaging, research on DNA, neonatal and adult brain imaging, and other applications. Optimal Imaging reduces a patient's exposure to harmful radiation with the help of non-ionizing radiation. It is widely used in biomedical research and medical care.

Optical Imaging Market Drivers:

  • Bolstering growth in biomedical and biopharmaceutical research is expected to propel the market expansion.

Optical imaging is an essential technique that provides useful information to researchers, pharmacists, and biotechnicians for studying complex human, animal, and plant models. Research in biomedical, biopharmaceutical, and medical care, especially in eye care, is contributing to the optical imaging market's growth. The National Institute for Occupational Safety and Health (NIOSH) reports that about 2000 US workers suffer from job-related eye injuries daily that require medical treatment.

  • Growing chronic disease prevalence has accelerated the market expansion.

Accurate glaucoma screening requires using novel optical imaging techniques for early diagnosis and treatment that would stop the progression to blindness. Vivo imaging, particularly whole-body Vivo imaging, enables the study of animal models of human diseases, reducing the rate of experimentation on animals and providing essential information in research studies. Other applications of Vivo imaging can be seen in bioluminescence, which is used in microbiology, and fluorescence methods in vivo imaging, which are commonly used in clinical research.

  • New technological developments are accelerating the market expansion.

New developments in optical imaging techniques, for instance, CT (Computed Tomography), MRI (Magnetic Resonance Imaging), and PET-CT (Position Emission Tomography - Computed Tomography), are widely applied in medical imaging techniques. Additionally, new software launches to bolster optical imaging are also taking place. For instance, Abbott Laboratories, in October 2023, launched its vascular imaging software "Ultreon 1.0", which integrates Artificial Intelligence and optical coherence tomography (OCT), which enables physicians to get a comprehensive view of coronary arteries.

Researchers have researched 3D optical imaging and 3D display, with applications in medicine, robotics, security, detection, visualization, and display abilities. For example, 3D medical imaging is a new technology that can improve disease prevention, diagnosis, and treatment in clinics and operating rooms. Optical imaging through imaging probes using bioluminescence, chemiluminescence, afterglow imaging, and NIR-II probes having macro-mesoscopic regimes are new advances in studying deep tissue imaging.

Optical Imaging Market Restraints:

  • Lack of clinical expertise is expected to restrain the market growth.

Optical imaging provides a major scope for disease detection and cancer care. However, the low penetration of optimal imaging, absorption, and scattering issues, and the lack of clinical instrumentation and expertise will likely hamper the optical imaging market's growth.

Optical Imaging Market Geographical Outlook

  • During the forecast period, North America is expected to hold a significant share of the optical imaging market.

North America is projected to account for a considerable market share due to increased research and technological advancements, and the surge in eye, brain, cancer, and other diseases, where optical imaging is majorly applied for better diagnosis. Well-established presence of market players, namely Heidelberg Engineering Inc., Carl Zeiss Meditec, Bruker Corporation, Leica Microsystems, and others, has also positively impacted the regional market growth.

Regional economies, namely the USA, are experiencing a high prevalence of vision impairment cases. According to the CDC ( Centres for Disease Control and Prevention), approximately 12 million people 40 years and above suffer from vision impairment in the United States, of which nearly 8 million cases remain untreated. Major eye diseases include Glaucoma, Diabetic Retinopathy, Cataracts, and Refractive Error.

Brain Diseases, mainly Alzheimer's, Brain Tumour, Dementia, and Parkinson's Disease, are resulting in deaths among people in the United States. Further, MRI Scanning is a technique used to detect images from the brain and deduce results. Breast and brain cancer constitutes one of the major cancer-related deaths in the US.

To better determine the cancer stages and their spread level within the body, imaging techniques such as Computed Tomography (PET-CT) Scans and Emission Tomography are used. Furthermore, emerging technologies such as Artificial Intelligence are also finding their way into medical imaging applications, providing new growth prospects for optical imaging.

Moreover, besides high applicability in the medical sector, optical imaging is also finding its way into space missions, where major space organizations such as NASA are investing in such technology.

Optical Imaging Market Key Developments

  • April 2024: Spectral Instruments Imaging launched the latest version of its vivo optical imaging software, "Aura 4.5". It is based on precise automation and a proprietary "Kinetics Mode" algorithm for capturing and analyzing real-time dynamic bioluminescent signals.
  • February 2024: Bruker Corporation announced the acquisition of Spectral Instruments Imaging LLC, a specialist in developing pre-clinical in-vivo optical imaging systems. The acquisition would enable Bruker to extend its "BioSpin Preclinical Imaging" division for disease research.
  • October 2023: Abbott Laboratories announced the launch of its new vascular imaging software, "Ultreon 1.0", in India. The first-of-its-kind intravascular imaging software combines Artificial Intelligence and Optical Coherence Tomography (OCT) to enable physicians to get a comprehensive view of blockage and blood flow in the coronary arteries.
  • September 2023: Revvity Inc. launched the " IVIS(R) Spectrum 2", "IVIS SpectrumCT 2", and "Quantum GX3 microCT" imaging systems, which aimed to drive innovations across the preclinical research process. The standard products aimed to elevate the sensitivity standard of both in-vivo and ex-vivo optical imaging.
  • September 2023: Yole Group's partner, PISEO, announced the launch of its optical imaging testing services. These services would use cutting-edge equipment that is reliable for the characterization of the entire optical imaging chain in high-value-added medical areas.

The Optical Imaging market is segmented and analyzed as follows:

By Technique

  • Endoscopy
  • Optical Coherence Tomography (OCT)
  • Photoacoustic Imaging
  • Raman Spectroscopy
  • Super-Resolution Microscopy
  • Diffuse Optical Topography

By Application

  • Ophthalmology
  • Oncology
  • Dentistry
  • Dermatology
  • Neurology
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OPTICAL IMAGING MARKET BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Endoscopy
  • 5.3. Optical Coherence Tomography (OCT)
  • 5.4. Photoacoustic Imaging
  • 5.5. Raman Spectroscopy
  • 5.6. Super-Resolution Microscopy
  • 5.7. Diffuse Optical Tomography (DOT)

6. OPTICAL IMAGING MARKET BY APPLICATIONS

  • 6.1. Introduction
  • 6.2. Ophthalmology
  • 6.3. Oncology
  • 6.4. Dentistry
  • 6.5. Dermatology
  • 6.6. Neurology
  • 6.7. Others

7. OPTICAL IMAGING MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. UAE
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. South Korea
    • 7.6.4. India
    • 7.6.5. Indonesia
    • 7.6.6. Taiwan
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. ZEISS Group
  • 9.2. Leica Microsystems
  • 9.3. Topcon Corporation
  • 9.4. Heidelberg Engineering GmbH
  • 9.5. Santec Corporation
  • 9.6. Luneau Technology USA
  • 9.7. Headwall Photonics
  • 9.8. Koninklijke Philips N.V.
  • 9.9. NIDEK CO., LTD.